Loading the content... Loading depends on your connection speed!

Shopping Cart - $0.00

Gastrointestinal Drugs Market Global Briefing 2017

Gastrointestinal Drugs Market Global Briefing 2017

From $1,000.00

Including: Antiulcerants, Vitamin And Minerals, Antacids, Antiemetics And Antinauseants, Antiobesity, Antidiarrhoeals
Covering: Takeda Pharmaceuticals, Allergan Plc., Novo Nordisk A/S, AstraZeneca Plc., Johnson & Johnson, Bayer AG, Otsuka Pharmaceutical Co., Ltd.


Clear selection
SKU: 2279. Categories: , .
Description

The top segments in the gastrointestinal drugs market include antiulcerants, vitamin and minerals, antacids, antiemetics and antinauseants, antiobesity and antidiarrhoeals. Antiulcerants was the largest segment in the gastrointestinal drugs market accounting for around 44% of the market.

Gastrointestinal Drugs Market Global Briefing from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the gastrointestinal drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the gastrointestinal drugs market and suggests approaches.

Reasons to Purchase

• Get up to date information available on the gastrointestinal drugs market globally.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.

 

Scope

Markets Covered: Antiulcerants, Vitamin And Minerals, Antacids, Antiemetics And Antinauseants, Antiobesity, Antidiarrhoeals
Companies Mentioned: Takeda Pharmaceuticals, Allergan Plc., Novo Nordisk A/S, AstraZeneca Plc., Johnson & Johnson, Bayer AG, Otsuka Pharmaceutical Co., Ltd.
Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Executive Summary
The gastrointestinal diseases drugs market covers medicines used for the treatment of ulcerative colitis, diverticular disease, perianal infections, anal fissures, hemorrhoids, constipation, and irritable bowel syndrome. The key gastrointestinal diseases drug categories include Anti-peptic agents (antacids, antagonists, Proton Pump Inhibitors, Sucralfate, and Misoprostol), antiemetics, adsorbents, anticholinergics, opiates, intestinal flora modifiers, emollient/surfactants, hyperosmotic, saline, and simulant/irritant.

The global gastrointestinal drugs market is expected to reach around $60 billion in 2020. This can be attributed to the expected increase in prevalence of obesity and digestive diseases globally.

Tranexamic Acid To Treat Gastrointestinal Bleeding - Drug manufacturing companies are offering tranexamic acid for the treatment of acute gastrointestinal bleeding. Tranexamic acid is a medication used to treat or prevent excessive blood loss from major trauma or surgery and is now finding applications for gastrointestinal diseases. Tranexamic acid reduces clot breakdown, thus reducing the duration and amount of bleeding. This reduces mortality rate (from 10% to 7.5%) and the probability of blood transfusion by about 30%. Major companies manufacturing tranexamic acid include Abbott Laboratories, Pfizer, GlaxoSmithKline and Bayer AG.
Table of Contents
Gastrointestinal Drugs Market Characteristics 5
Gastrointestinal Drugs Market Historic Growth 7
Gastrointestinal Drugs Market Forecast Growth 8
Gastrointestinal Drugs Market Segmentation 9
Global Gastrointestinal Drugs Market, Split By Segments, 2016, $ Billion 9
Antiulcerants 10
Vitamins And Minerals 10
Antacids 10
Antiemetics And Antinauseants 10
Antiobesity 10
Antidiarrhoeals 10
Global Gastrointestinal Drugs Market, Historic and Forecast, Split By Segments, 2012-2020 11
Gastrointestinal Drugs Market Geography Regional and Country Comparison 13
Global Gastrointestinal Drugs Market, Split By Regions, 2016 13
Global Gastrointestinal Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 15
Global Gastrointestinal Drugs Market, Split By Country, 2016 17
Global Gastrointestinal Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020 19
Gastrointestinal Drugs Market Competitive Landscape 21
Takeda Pharmaceuticals 22
Allergan Plc. 22
Novo Nordisk A/S 22
AstraZeneca Plc. 22
Johnson & Johnson 22
Bayer AG 22
Otsuka Pharmaceutical Co., Ltd. 22
Takeda Pharmaceuticals 23
Allergan 23
Novo Nordisk 24
Gastrointestinal Drugs Market Key Mergers And Acquisitions 25
Valeant Acquired Salix Pharmaceuticals 25
Celgene Acquired Receptos 25
Shire Acquired Dyax Corp. 25
Shire Acquired NPS Pharmaceuticals 25
Allergan Acquired AstraZeneca’s IBD Drug 25
Shire Acquired Meritage Pharma 26
Zydus Acquired Albert David 26
Gastrointestinal Drugs Market Trends And Strategies 27
Tranexamic Acid To Treat Gastrointestinal Bleeding 27
Increasing R&D Activities 27
Cost-effective Biosimilars To Treat Gastrointestinal Diseases 27
Appendix 28
NAICS Definitions Of Industry Covered In This Report 28
Definition Of Market Covered In This Report 28
Abbreviations 28
Currencies 29
Research Methodology 29
Research Inquiries 30
The Business Research Company 30

List of Figures
Figure 1: Global Gastrointestinal Drugs Market, Historic Market Size, 2012-2016, $ Billion 7
Figure 2: Global Gastrointestinal Drugs Market, Forecast Market Size, 2016 – 2020, $ Billion 8
Figure 3: Global Gastrointestinal Drugs Market, Split By Segments, 2016, $ Billion 9
Figure 4: Global Gastrointestinal Drugs Market, Historic and Forecast, Split By Segment, 2012 – 2020 11
Figure 5: Global Gastrointestinal Drugs Market, Split By Region, 2016, $ Billion 13
Figure 6: Global Gastrointestinal Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 15
Figure 7: Global Gastrointestinal Drugs Market, Split By Country, 2016, $ Billion 17
Figure 8: Global Gastrointestinal Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020 19
Figure 9: Global Gastrointestinal Drugs Market, Key Competitor Market Shares, 2016, Percentage (%) 21

List of Tables
Table 1: Global Gastrointestinal Drugs Market, Historic Market Size, 2012-2016, $ Billion 7
Table 2: Global Gastrointestinal Drugs Market, Forecast Market Size, 2016 – 2020, $ Billion 8
Table 3: Global Gastrointestinal Drugs Market, Split By Segments, 2016, $ Billion 10
Table 4: Global Gastrointestinal Drugs Market, Historic and Forecast, Split By Segment, 2012 – 2020 11
Table 5: Global Gastrointestinal Drugs Market, Split By Region, 2016, $ Billion 14
Table 6: Global Gastrointestinal Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 15
Table 7: Global Gastrointestinal Drugs Market, Split By Country, 2016, $ Billion 17
Table 8: Global Gastrointestinal Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020 19
Table 9: Global Gastrointestinal Drugs Market, Key Competitor Market Shares, 2016, Percentage (%) 22
Get Customized Report
Please fill in your details. Our team will get back to you